Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-05-30 Sale | 2019-06-03 4:00 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 10,000 | $25.2 | $252,050 | 64,561 (Direct) | View |
| 2019-05-28 Sale | 2019-05-30 4:01 pm | RHYTHM PHARMACEUTICALS INC. | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 15,000 | $25.42 | $381,350 | 139,851 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-05-30 Exercise | 2019-06-03 4:00 pm | N/A 2025-11-16 | RHYTHM PHARMACEUTICALS INC. | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 10,000 | $0 | 64,561 (Direct) | View |
| 2019-05-30 Exercise | 2019-06-03 4:00 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 10,000 | $4.59 | 64,561 (Direct) | View |
| 2019-05-28 Exercise | 2019-05-30 4:01 pm | N/A 2025-11-16 | RHYTHM PHARMACEUTICALS INC. | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 15,000 | $0 | 139,851 (Direct) | View |
| 2019-05-28 Exercise | 2019-05-30 4:01 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 14,860 | $4.59 | 139,851 (Direct) | View |
| 2019-05-28 Exercise | 2019-05-30 4:01 pm | N/A N/A | RHYTHM PHARMACEUTICALS INC. | RYTM | Van der Ploeg Leonardus H.T. Chief Scientific Officer | 140 | $6.14 | 139,851 (Direct) | View |